Sandbox:Aisha: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
*An Israeli based [[population study]] with 7,807 participants was published online on the 23rd of July 2020<ref name="urlLow plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study - Merzon - - The FEBS Journal - Wiley Online Library">{{cite web |url=https://febs.onlinelibrary.wiley.com/doi/abs/10.1111/febs.15495 |title=Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study - Merzon - - The FEBS Journal - Wiley Online Library |format= |work= |accessdate=}}</ref>. 10.1% (782) of these patients were [[COVID-19]] positive. The study found that low [[vitamin D]] levels may be an independent [[risk factor]] for [[COVID-19]] infection and hospitalization.
 
The association between [[Thrombosis|thromboembotic events]] and [[malignancy]] was made by Armand Trousseau in the year 1865. In 1926, Dr. Benjamin Sacks and Dr. Emmanuel Libman published cases of "valvular masses" that were examined clinically and during autopsies and found to be free of all microorganisms. These masses were initially named "indeterminate endocarditis".

Revision as of 21:33, 22 August 2020

The association between thromboembotic events and malignancy was made by Armand Trousseau in the year 1865. In 1926, Dr. Benjamin Sacks and Dr. Emmanuel Libman published cases of "valvular masses" that were examined clinically and during autopsies and found to be free of all microorganisms. These masses were initially named "indeterminate endocarditis".